JPMorgan Chase & Co. grew its stake in AMERISAFE, Inc. (NASDAQ:AMSF - Free Report) by 17.5% during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 34,726 shares of the insurance provider's stock after acquiring an additional 5,168 shares during the quarter. JPMorgan Chase & Co. owned about 0.18% of AMERISAFE worth $1,678,000 at the end of the most recent quarter.
A number of other large investors have also made changes to their positions in AMSF. State Street Corp lifted its stake in shares of AMERISAFE by 8.5% during the 3rd quarter. State Street Corp now owns 811,561 shares of the insurance provider's stock worth $39,223,000 after purchasing an additional 63,638 shares during the period. Barclays PLC boosted its position in shares of AMERISAFE by 365.6% in the third quarter. Barclays PLC now owns 33,219 shares of the insurance provider's stock worth $1,605,000 after acquiring an additional 26,084 shares during the last quarter. Jane Street Group LLC grew its holdings in AMERISAFE by 70.6% in the third quarter. Jane Street Group LLC now owns 41,299 shares of the insurance provider's stock valued at $1,996,000 after purchasing an additional 17,084 shares during the period. Intech Investment Management LLC acquired a new position in AMERISAFE during the second quarter worth approximately $591,000. Finally, BNP Paribas Financial Markets raised its stake in AMERISAFE by 6.9% during the third quarter. BNP Paribas Financial Markets now owns 5,882 shares of the insurance provider's stock worth $284,000 after purchasing an additional 381 shares during the period. Institutional investors and hedge funds own 97.41% of the company's stock.
Analyst Ratings Changes
Several brokerages have recently issued reports on AMSF. Truist Financial boosted their price objective on shares of AMERISAFE from $48.00 to $54.00 and gave the company a "hold" rating in a research note on Friday, October 25th. JMP Securities reiterated a "market outperform" rating and issued a $65.00 target price on shares of AMERISAFE in a report on Tuesday, October 15th.
View Our Latest Analysis on AMSF
AMERISAFE Stock Down 0.5 %
Shares of AMERISAFE stock traded down $0.26 during trading hours on Thursday, hitting $50.04. The company's stock had a trading volume of 55,763 shares, compared to its average volume of 73,176. The company has a market capitalization of $953.26 million, a PE ratio of 15.64 and a beta of 0.35. The business has a fifty day moving average of $53.86 and a 200 day moving average of $51.09. AMERISAFE, Inc. has a 1-year low of $41.97 and a 1-year high of $60.24.
AMERISAFE (NASDAQ:AMSF - Get Free Report) last released its quarterly earnings data on Wednesday, October 23rd. The insurance provider reported $0.58 EPS for the quarter, beating the consensus estimate of $0.56 by $0.02. AMERISAFE had a return on equity of 16.50% and a net margin of 19.49%. The company had revenue of $78.70 million for the quarter, compared to analyst estimates of $75.38 million. During the same period last year, the company posted $0.61 earnings per share. On average, sell-side analysts anticipate that AMERISAFE, Inc. will post 2.45 earnings per share for the current fiscal year.
AMERISAFE Company Profile
(
Free Report)
AMERISAFE, Inc, an insurance holding company, underwrites workers' compensation insurance in the United States. The company provides benefits to injured employees for temporary or permanent disability, death, and medical and hospital expenses. It sells its products through retail and wholesale brokers and agents; and small and mid-sized employers engaged in hazardous industries, including construction, trucking, logging and lumber, agriculture, manufacturing, telecommunications, and maritime.
Further Reading

Before you consider AMERISAFE, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AMERISAFE wasn't on the list.
While AMERISAFE currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.